Detailed answers about SQUADRON PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was SQUADRON PHARMACEUTICALS LIMITED founded?
SQUADRON PHARMACEUTICALS LIMITED was officially incorporated on 17 January 2025 and is registered under company number 16190642. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SQUADRON PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SQUADRON PHARMACEUTICALS LIMITED?
SQUADRON PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SQUADRON PHARMACEUTICALS LIMITED do?
SQUADRON PHARMACEUTICALS LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 70229 - Management consultancy activities other than financial management, 82990 - Other business support service activities n.e.c., 96090 - Other service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is SQUADRON PHARMACEUTICALS LIMITED's registered address?
The registered office address of SQUADRON PHARMACEUTICALS LIMITED is 9 BLUE ROCK DRIVE, AYLESBURY, ENGLAND, HP18 1AW. This is the official address filed with Companies House for legal and statutory correspondence.
Is SQUADRON PHARMACEUTICALS LIMITED financially stable?
Financial accounts for SQUADRON PHARMACEUTICALS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.